Intensity Therapeutics, Inc. (INTS) Misses Q1 EPS by 4c

Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q1 EPS of ($0.22), $0.04 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.

You May Also Be Interested In

• Getty Realty (GTY) Reiterated at Market Outperform by Citizens on Investment Volumes
• Franklin BSP Realty Trust (FBRT) Reiterated at Market Outperform by Citizens
• Jefferies Starts China Oilfield Services (A-Shares) (601808:CH) at Buy